American Journal of Cardiology
Volume 102, Issue 6 , Pages 749-754 , 15 September 2008

Comparison of Brain Natriuretic Peptide Plasma Levels Versus Logistic EuroSCORE in Predicting In-Hospital and Late Postoperative Mortality in Patients Undergoing Aortic Valve Replacement for Symptomatic Aortic Stenosis

  • Giovanni Battista Pedrazzini, MD

      Affiliations

    • Division of Cardiology, Cardiocentro Ticino, Lugano, Switzerland
    • ,
  • Serge Masson, PhD

      Affiliations

    • Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy
    • ,
  • Roberto Latini, MD

      Affiliations

    • Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy
    • ,
  • Catherine Klersy, MD, MSc

      Affiliations

    • Service of Biometry & Clinical Epidemiology, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy
    • ,
  • Maria Grazia Rossi, MD

      Affiliations

    • Division of Cardiology, Cardiocentro Ticino, Lugano, Switzerland
    • ,
  • Elena Pasotti, MD

      Affiliations

    • Division of Cardiology, Cardiocentro Ticino, Lugano, Switzerland
    • ,
  • Francesco Fulvio Faletra, MD

      Affiliations

    • Division of Cardiology, Cardiocentro Ticino, Lugano, Switzerland
    • ,
  • Francesco Siclari, MD

      Affiliations

    • Division of Cardiac Surgery, Cardiocentro Ticino, Lugano, Switzerland
    • ,
  • Fabrizio Minervini, MD

      Affiliations

    • Division of Cardiac Surgery, Cardiocentro Ticino, Lugano, Switzerland
    • ,
  • Tiziano Moccetti, MD

      Affiliations

    • Division of Cardiology, Cardiocentro Ticino, Lugano, Switzerland
    • ,
  • Angelo Auricchio, MD, PhD

      Affiliations

    • Division of Cardiology, Cardiocentro Ticino, Lugano, Switzerland
    • Corresponding Author InformationCorresponding author: Tel: 41-91-805-3340; fax: 41-91-805-3167

Received 6 February 2008 ,Revised 29 April 2008 ,Accepted 29 April 2008.

References 

  1. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg. 1999;16:9–13
  2. Nashef SA, Roques F, Hammill BG, Peterson ED, Michel P, Grover FL, et al. Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery. Eur J Cardiothorac Surg. 2002;22:101–105
  3. Roques F, Nashef SA, Michel P, Gauducheau E, de Vincentiis C, Baudet E, et al Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19,030 patients. Eur J Cardiothorac Surg. 1999;15:816–822
  4. Roques F, Michel P, Goldstone AR, Nashef SAM. The logistic EuroSCORE [Letter to Editor]. European Heart J. 2003;24:1–2
  5. Bhatti F, Grayson AD, Grotte G, Fabri BM, Au J, Jones M, et al. The logistic EuroSCORE in cardiac surgery: how well does it predict operative risk?. Heart. 2006;92:1817–1820
  6. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, et al Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161–167
  7. Weber M, Dill T, Arnold R, Rau M, Ekinci O, Muller KD, et al. N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris. Am Heart J. 2004;148:612–620
  8. De Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet. 2003;362:316–322
  9. Berger R, Huelsman M, Strecker K, Bojic A, Moser P, Stanek B, et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation. 2002;105:2392–2397
  10. Suzuki S, Yoshimura M, Nakayama M, Mizuno Y, Harada E, Ito T, et al Plasma level of B-type natriuretic peptide as a prognostic marker after acute myocardial infarction: a long-term follow-up analysis. Circulation. 2004;110:1387–1391
  11. Patel DN, Bailey SR. Role of BNP in patients with severe asymptomatic aortic stenosis. Eur Heart J. 2004;25:1972–1973
  12. Weber M, Arnold R, Rau M, Brandt R, Berkovitsch A, Mitrovic V, et al. Relation of N-terminal pro–B-type natriuretic peptide to severity of valvular aortic stenosis. Am J Cardiol. 2004;94:740–745
  13. Gerber IL, Stewart RA, Legget ME, West TM, French RL, Sutton TM, et al. Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis. Circulation. 2003;107:1884–1890
  14. Gerber IL, Legget ME, West TM, Richards AM, Stewart RA. Usefulness of serial measurement of N-terminal pro-brain natriuretic peptide plasma levels in asymptomatic patients with aortic stenosis to predict symptomatic deterioration. Am J Cardiol. 2005;95:898–901
  15. Kupari M, Turto H, Lommi J, Mäkiyärvi , Parikka H. Transcardiac gradients of N-terminal B-type natriuretic peptide in aortic valve stenosis. Eur J Heart Fail. 2005;7:809–814
  16. Neverdal NO, Knudsen CW, Husebye T, Vengen OA, Pepper J, Lie M, et al. The effect of aortic valve replacement on plasma B-type natriuretic peptide in patients with severe aortic stenosis: one year follow-up. Eur J Heart Fail. 2006;8:257–262
  17. Qi W, Mathisen P, Kjesshus J, Simonsen S, Bjornerheim R, Endresen K, et al. Natriuretic peptides in patients with aortic stenosis. Am Heart J. 2001;142:725–732
  18. Salehian O, Chan KL. Should brain natriuretic peptides be measured in patients with aortic valve disease?. Eur Heart J. 2005;26:951–952
  19. Weber M, Arnold R, Rau M, Elsaesser A, Brandt R, Mitrovic V, et al. Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease. Eur Heart J. 2005;1023–1030
  20. Elíasdóttir SB, Klemenzson G, Torfason B, Valsson F. Brain natriuretic peptide is a good predictor for outcome in cardiac surgery. Acta Anaesthesiol Scand. 2008;52:182–187
  21. Bergler-Klein J, Klaar U, Heger M, Rosenhek R, Mundigler G, Gabriel H, et al. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation. 2004;109:2302–2308
  22. Weber M, Hausen M, Arnold R, Nef H, Moellman H, Berkowitsch A, et al. Prognostic value of N-terminal pro–B-type natriuretic peptide for conservatively and surgically treated patients with aortic valve stenosis. Heart. 2006;92:1639–1644
  23. Toumpoulis IK, Anagnostopoulos CE, Toumpoulis SK, DeRose JJ, Swistel DG. EuroSCORE predicts long-term mortality after heart valve surgery. Ann Thorac Surg. 2005;79:1902–1908
  24. Giannakoulas G, Hatzitolios A, Karvounis H, Koliakos G, Charitandi A, Dimitroulas T, et al. N-terminal pro-brain natriuretic peptide levels are elevated in patients with acute ischemic stroke. Angiology. 2005;56:723–730
  25. Iltumur K, Yavavli A, Apak I, Ariturk Z, Toprak N. Elevated plasma N-terminal pro-brain natriuretic peptide levels in acute ischemic stroke. Am Heart J. 2006;151:1115–1122
  26. Heart Protection Study Collaborative GroupEmberson JR, Ng LL, Armitage J, Bowman L, Parish S, Collins R. N-terminal pro–B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study. J Am Coll Cardiol. 2007;49:311–319

PII: S0002-9149(08)00845-X

doi: 10.1016/j.amjcard.2008.04.055

American Journal of Cardiology
Volume 102, Issue 6 , Pages 749-754 , 15 September 2008

Article Tools

* Image Usage & Resolution